logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Dementia

    FiltersReset Filters
    7 results

    • ioflupane i 123

      (IOFLUPANE I-123)
      Curium US LLC
      Usage: Ioflupane I 123 Injection is indicated as an adjunct for striatal dopamine transporter visualization via SPECT brain imaging in adults suspected of having Parkinsonian syndromes or dementia with Lewy bodies.

    • memantine hydrochloride

      (Memantine hydrochloride)
      Zydus Pharmaceuticals USA Inc.
      Usage: Memantine hydrochloride extended-release capsules are indicated for treating moderate to severe dementia associated with Alzheimer's disease.

    • memantine hydrochloride

      (Memantine)
      Amneal Pharmaceuticals of New York LLC
      Usage: Memantine hydrochloride tablets are indicated for the treatment of moderate to severe Alzheimer’s disease-related dementia.

    • rivastigmine

      (Rivastigmine)
      NorthStar RxLLC
      Usage: Rivastigmine transdermal system is indicated for treating dementia of the Alzheimer's type in patients with mild, moderate, or severe Alzheimer's disease, as well as mild-to-moderate dementia associated with Parkinson's disease.

    • rivastigmine tartrate

      (Rivastigmine Tartrate)
      Alembic Pharmaceuticals Limited
      Usage: Rivastigmine tartrate capsules are indicated for treating mild to moderate dementia in patients with Alzheimer's disease and for mild to moderate dementia associated with Parkinson's disease.

    • rivastigmine tartrate

      (Rivastigmine Tartrate)
      Modavar Pharmaceuticals LLC
      Usage: Rivastigmine tartrate capsules are indicated for treating mild-to-moderate dementia associated with Alzheimer's disease and dementia related to Parkinson's disease.

    • rivastigmine tartrate

      (Rivastigmine Tartrate)
      Alembic Pharmaceuticals Inc.
      Usage: Rivastigmine tartrate capsules are indicated for treating mild-to-moderate dementia in Alzheimer's disease and mild-to-moderate dementia associated with Parkinson's disease.